Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Tax
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Tax of $7.60 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2026-05-06
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for the quarter ending 2026-03-31 was $7.60M.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for the quarter ending 2025-09-30 was $7.50M.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for the quarter ending 2025-06-30 was -$24.50M, a 944.83% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for the quarter ending 2025-03-31 was -$12.00M, a 203.45% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for fiscal 2018 was $16.20M.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for fiscal 2017 was -$32.20M, a 8150.00% decline from fiscal 2016.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for fiscal 2016 was $400.00K.
- Edwards Lifesciences Corporation other comprehensive income (loss), tax for fiscal 2015 was -$9.90M.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $7.60M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | $7.50M 10-Q · filed 2025-11-05 | -$17.00M derived: sum of 2 quarters · filed 2025-11-05 | -$29.00M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2025-06-30 | -$24.50M 10-Q · filed 2025-11-05 | -$36.50M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2025-03-31 | -$12.00M 10-Q · filed 2026-05-06 | |||
| 2024-09-30 | -$17.50M 10-Q · filed 2025-11-05 | -$14.60M derived: sum of 2 quarters · filed 2025-11-05 | -$3.00M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $2.90M 10-Q · filed 2025-11-05 | $14.50M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $11.60M 10-Q · filed 2025-11-05 | |||
| 2019-09-30 | $6.60M 10-Q · filed 2019-10-25 | |||
| 2019-03-31 | $3.80M 10-Q · filed 2019-04-26 | $200.00K derived: sum of 2 quarters · filed 2019-04-26 | $4.00M derived: sum of 3 quarters · filed 2019-04-26 | $20.20M derived: sum of 4 quarters · filed 2019-04-26 |
| 2018-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $200.00K derived: sum of 2 quarters · filed 2019-02-15 | $16.40M derived: sum of 3 quarters · filed 2019-02-15 | $16.20M 10-K · filed 2019-02-15 |
| 2018-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $20.00M derived: sum of 2 quarters · filed 2018-10-26 | $19.80M 10-Q · filed 2018-10-26 | $18.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-06-30 | $16.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $16.00M 10-Q · filed 2018-07-27 | $14.70M derived: sum of 3 quarters · filed 2019-02-15 | $2.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-03-31 | -$200.00K 10-Q · filed 2018-04-27 | -$1.50M derived: sum of 2 quarters · filed 2019-02-15 | -$13.70M derived: sum of 3 quarters · filed 2019-02-15 | -$27.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$13.50M derived: sum of 2 quarters · filed 2019-02-15 | -$27.30M derived: sum of 3 quarters · filed 2019-02-15 | -$32.20M 10-K · filed 2019-02-15 |
| 2017-09-30 | -$12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$26.00M derived: sum of 2 quarters · filed 2017-10-27 | -$30.90M 10-Q · filed 2017-10-27 | -$13.90M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$13.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$18.70M 10-Q · filed 2017-07-28 | -$1.70M derived: sum of 3 quarters · filed 2019-02-15 | |
| 2017-03-31 | -$4.90M 10-Q · filed 2017-04-28 | $12.10M derived: sum of 2 quarters · filed 2019-02-15 | ||
| 2016-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $400.00K 10-K · filed 2019-02-15 | ||
| 2016-09-30 | -$16.60M 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | -$9.90M 10-K · filed 2018-02-16 | |||
| 2010-12-31 | $4.30M 10-K · filed 2011-02-28 | |||
| 2009-12-31 | $900.00K 10-K · filed 2011-02-28 | |||
| 2008-12-31 | $4.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |